Weight Loss Drug Mounjaro to Be Launched in India in 2025; Know How It Tackles Obesity
Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands ...
McKnight's Long-Term Care News3h
FDA approves Zepbound for sleep apnea in patients with obesity
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
Elon Musk admits to being on Ozempic-like weight loss drug in Santa Claus post on Christmas
Musk posted a pictured of himself in a Santa costume posing in front of a Christmas tree as he made the admission.
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
Alaska Dispatch News14hOpinion
Opinion: We’ve accepted Wegovy and Zepbound. The next phase is harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
This anti-diabetic drug used for weight loss has been approved by US FDA: When will India see its launch?
The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in ...
WQOW22h
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
The Sacramento Observer23h
What Black Folks Say About Weight Loss Meds and the Holidays
Branneisha Cooper was terrified of attending her first holiday gathering after starting Mounjaro. The 28-year-old ...